Retinal degeneration caused by alterations in protein O-sulfation

蛋白质 O-硫酸化改变引起的视网膜变性

基本信息

项目摘要

The overall goal of this proposal is to investigate the role of protein tyrosyl-sulfation in normal retinal function. The intermediate aims include the identification of retinal proteins that are sulfated by tyrosylprotein sulfotransferases and determine how lack of either (or both) of these enzymes influence retinal function. There are two distinct TPST isoenzymes present in most tissues. These two enzymes are responsible for the post-translational tyrosine O-sulfation of cellular proteins. Neither these enzymes nor their targets have been studied in the retina or other ocular tissues. We have generated knockout mice for TPST-1 & 2. These two mice, and the double knockout obtained by crossbreeding, exhibit different retinal defects in retinal development, function and aging. Lack of TPST-1 results in the retardation of functional development. Moreover, these mice demonstrate a slow retinal degeneration characterized by a gradual loss of scotopic and photopic electroretinography (ERGs) that become very apparent at 4 months of age (-30% loss). Histologic examination of P120 Tpstrl- retinas revealed a reduced number of nuclei in ONL (9 rows at P120 versus 11 rows at P50) and INL (4 rows at P120 versus 5-6 at P50). Unlike TpsWI - retinas, TpstZI - retinas never fully develop to the wild-type level. This very clearly demonstrates a direct role for TPST-2, or its protein products, in retinal maturity. In Aim 1, we will characterize the presence, localization and biochemical behavior of retinal TPST-1 and TPST-2 during development. These experiments will be performed in normal mouse retinas from embryonic day 10 to 2 years of age utilizing antibodies that are specific for TPST-1, TPST-2, and to sulfotyrosine. As part of this aim, we will identify the proteins modified by TPST-1/2 using classic immunoaffinity purification techniques and MS and MS/MS. In Aim 2, we will fully characterize retinal phenotypes caused by lack of TPST-1, TPST-2 or both. Characterization will be performed structurally at the light and electron microscopic levels, functionally by scotopic and photopic ERGs and suction electrode recordings, and biochemically by analysis of the sulfation of retinal proteins and expression of the targets of TPST-1/2 by SOS-PAGE. These studies will, for the first time, shed light on the role of TPST-1 and 2 in protein sulfation in the retina. Further, they will increase our understanding of retinal development and the mechanism(s) involved in retinal degeneration.
该提案的总体目标是研究蛋白质酪氨酰硫酸化的作用 在正常的视网膜功能中。中间目标包括鉴定由酪氨酰蛋白磺基转移酶硫酸化的视网膜蛋白,并确定缺乏这些酶中的一种(或两种)如何影响视网膜功能。大多数组织中存在两种不同的 TPST 同工酶。这两种酶负责细胞蛋白质的翻译后酪氨酸 O-硫酸化。尚未在视网膜或其他眼组织中研究这些酶及其靶标。我们已经培育出了TPST-1和2的基因敲除小鼠。这两只小鼠以及通过杂交获得的双基因敲除小鼠,在视网膜发育、功能和衰老方面表现出不同的视网膜缺陷。 TPST-1 缺乏会导致功能发育迟缓。此外,这些小鼠表现出缓慢的视网膜变性,其特征是暗视和明视视网膜电图(ERG)逐渐丧失,在 4 个月大时变得非常明显(-30% 丧失)。 P120 Tpstrl-视网膜的组织学检查显示 ONL(P120 为 9 行,P50 为 11 行)和 INL(P120 为 4 行,P50 为 5-6 行)细胞核数量减少。与 TpsWI(视网膜)不同,TpstZI(视网膜)永远不会完全发育到野生型水平。这非常清楚地证明了 TPST-2 或其蛋白质产物在视网膜成熟中的直接作用。在目标 1 中,我们将描述视网膜 TPST-1 和 TPST-2 在发育过程中的存在、定位和生化行为。这些实验将在胚胎 10 天至 2 岁时的正常小鼠视网膜中进行,使用对 TPST-1、TPST-2 和磺基酪氨酸具有特异性的抗体。作为这一目标的一部分,我们将使用经典的免疫亲和纯化技术以及 MS 和 MS/MS 来鉴定 TPST-1/2 修饰的蛋白质。在目标 2 中,我们将全面描述由于 TPST-1、TPST-2 或两者缺乏而导致的视网膜表型。将在光和电子显微镜水平上进行结构表征,通过暗视和明视 ERG 和抽吸电极记录进行功能表征,并通过 SOS-PAGE 分析视网膜蛋白的硫酸化和 TPST-1/2 靶标的表达进行生化表征。 这些研究将首次揭示 TPST-1 和 2 在视网膜蛋白质硫酸化中的作用。此外,它们将增加我们对视网膜发育和视网膜变性机制的了解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUAYYAD R AL-UBAIDI其他文献

MUAYYAD R AL-UBAIDI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUAYYAD R AL-UBAIDI', 18)}}的其他基金

Retinal degeneration caused by alterations in protein O-sulfation
蛋白质 O-硫酸化改变引起的视网膜变性
  • 批准号:
    7525495
  • 财政年份:
    2009
  • 资助金额:
    $ 37.14万
  • 项目类别:
Retinal degeneration caused by alterations in protein tyrosine O-sulfation
蛋白质酪氨酸 O-硫酸化改变引起的视网膜变性
  • 批准号:
    8437028
  • 财政年份:
    2009
  • 资助金额:
    $ 37.14万
  • 项目类别:
MOLECULAR BIOLOGY/FUNCTIONAL GENOMICS
分子生物学/功能基因组学
  • 批准号:
    7720539
  • 财政年份:
    2008
  • 资助金额:
    $ 37.14万
  • 项目类别:
Compacted DNA Nanoparticles for Ocular Therapy
用于眼部治疗的压缩 DNA 纳米颗粒
  • 批准号:
    10246311
  • 财政年份:
    2008
  • 资助金额:
    $ 37.14万
  • 项目类别:
FUNCTIONAL GENOMICS
功能基因组学
  • 批准号:
    7610507
  • 财政年份:
    2007
  • 资助金额:
    $ 37.14万
  • 项目类别:
FUNCTIONAL GENOMICS
功能基因组学
  • 批准号:
    7381946
  • 财政年份:
    2006
  • 资助金额:
    $ 37.14万
  • 项目类别:
FUNCTIONAL GENOMICS
功能基因组学
  • 批准号:
    7171169
  • 财政年份:
    2005
  • 资助金额:
    $ 37.14万
  • 项目类别:
FUNCTIONAL GENOMICS
功能基因组学
  • 批准号:
    6982248
  • 财政年份:
    2004
  • 资助金额:
    $ 37.14万
  • 项目类别:
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS
视网膜变性:分子和生物化学方面
  • 批准号:
    6577662
  • 财政年份:
    2003
  • 资助金额:
    $ 37.14万
  • 项目类别:
RETINAL DEGENERATION: MOLECULAR AND BIOCHEMICAL ASPECTS
视网膜变性:分子和生物化学方面
  • 批准号:
    6693051
  • 财政年份:
    2003
  • 资助金额:
    $ 37.14万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了